Skip to content
10-Q

Quarterly Report

agilon health, inc. AGL

0001628280-26-031270

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 16.68M sh
Shares Diluted Q1 2026 · Mar 31, 2026 16.66M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 16.52M sh
Capex Q1 2026 · Mar 31, 2026 $3.1M
Capex Q1 2026 · Mar 31, 2025 $3.85M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $23.73M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$31.99M
Long Term Debt Q1 2026 · Mar 31, 2026 $15.28M
Long Term Debt Q1 2026 · Dec 31, 2025 $15.75M
Short Term Debt Q1 2026 · Mar 31, 2026 $14.75M
Short Term Debt Q1 2026 · Dec 31, 2025 $19.24M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $139.99M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $173.71M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.27B
Current Liabilities Q1 2026 · Dec 31, 2025 $1.08B
Total Liabilities Q1 2026 · Mar 31, 2026 $1.32B
Total Liabilities Q1 2026 · Dec 31, 2025 $1.14B
Current Assets Q1 2026 · Mar 31, 2026 $1.32B
Current Assets Q1 2026 · Dec 31, 2025 $1.1B
Total Assets Q1 2026 · Mar 31, 2026 $1.5B
Total Assets Q1 2026 · Dec 31, 2025 $1.27B
Eps Diluted Q1 2026 · Mar 31, 2026 $2.94
Eps Diluted Q1 2026 · Mar 31, 2025 $0.73
Eps Basic Q1 2026 · Mar 31, 2026 $2.95
Eps Basic Q1 2026 · Mar 31, 2025 $0.73
Sga Expense Q1 2026 · Mar 31, 2026 $54.23M
Sga Expense Q1 2026 · Mar 31, 2025 $65.96M
Net Income Q1 2026 · Mar 31, 2026 $48.92M
Net Income Q1 2026 · Mar 31, 2025 $12.11M
Operating Income Q1 2026 · Mar 31, 2026 $4M
Operating Income Q1 2026 · Mar 31, 2025 −$22.11M
Revenue Q1 2026 · Mar 31, 2026 $1.42B
Revenue Q1 2026 · Mar 31, 2025 $1.53B